By: Atty. Gregorio B. Austral, CPA
Before the next virus
The COVID-19 pandemic taught us that a health emergency is never merely a medical event. It is also a test of law, institutions and public trust. When borders closed, hospitals filled and vaccines became the world’s most precious commodity, the Philippines discovered the high price of entering a crisis without sufficient domestic research capacity, laboratories, trained specialists and reliable access to life-saving technologies. The lesson is plain: preparedness cannot begin only after the first outbreak.
Republic Act No. 12290, the Virology and Vaccine Institute of the Philippines (VIP) Act, which took effect in 2025 is an important answer to that lesson. It creates a national institute devoted to research on viruses and other disease-causing agents, including work on diagnostics, therapeutics and vaccines. Its mandate reaches beyond human illness to pathogens affecting animals, plants and the environment—an acknowledgment that the next grave threat may cross species and sectors before it reaches our hospitals.
This “One Health” approach is among the law’s strongest features. COVID-19 showed how quickly a localized disease can become a global emergency, how misinformation can travel faster than scientific consensus, and how dependence on foreign supply chains can leave poorer countries waiting. By linking virology, molecular biology, bioinformatics, genome laboratories, biobanks and high-containment facilities, the law seeks to build the scientific infrastructure needed to detect danger early and respond on the basis of evidence rather than fear or improvisation.
But an institute created by statute does not become effective by the mere force of its name. The pandemic also taught us that laws fail when implementation is fragmented, funding is uncertain, procurement lacks transparency, and agencies guard their jurisdictions instead of sharing information. The VIP must therefore be adequately funded, professionally led and protected from political interference. Its biosafety rules, research priorities and public communications must be clear, credible and open to scrutiny.
The rule of law requires more than emergency powers after calamity strikes; it requires durable institutions before the emergency arrives. In a future pandemic, the VIP could shorten the time between the discovery of a pathogen and the development of tests, treatments and vaccine candidates. It could also give policymakers dependable local evidence, reduce our vulnerability to overseas shortages, train Filipino scientists and sustain international cooperation without surrendering national capacity.
Republic Act No. 12290 is thus not simply a law about laboratories. It is a covenant with the future: that the suffering, isolation and uncertainty of COVID-19 will not be remembered only in memorials, but translated into competent public institutions. Before the next virus tests our borders and our resolve, the State must make this law real. Preparedness, after all, is the most humane form of emergency response—and the surest proof that government has learned.